Silicosis and silica-induced autoimmunity in the diversity outbred mouse JM Mayeux, GM Escalante, JM Christy, RD Pawar, DH Kono, KM Pollard Frontiers in immunology 9, 874, 2018 | 60 | 2018 |
A Pentavalent Epstein-Barr Virus-Like Particle Vaccine Elicits High Titers of Neutralizing Antibodies against Epstein-Barr Virus Infection in Immunized Rabbits GM Escalante, J Foley, LZ Mutsvunguma, E Rodriguez, DH Mulama, ... Vaccines 8 (2), 169, 2020 | 27 | 2020 |
A multivalent Kaposi sarcoma-associated herpesvirus-like particle vaccine capable of eliciting high titers of neutralizing antibodies in immunized rabbits DH Mulama, LZ Mutsvunguma, J Totonchy, P Ye, J Foley, GM Escalante, ... Vaccine 37 (30), 4184-4194, 2019 | 26 | 2019 |
Identification of multiple potent neutralizing and non-neutralizing antibodies against Epstein-Barr virus gp350 protein with potential for clinical application and as reagents … LZ Mutsvunguma, E Rodriguez, GM Escalante, M Muniraju, JC Williams, ... Virology 536, 1-15, 2019 | 23 | 2019 |
Induction of systemic autoimmunity by a xenobiotic requires endosomal TLR trafficking and signaling from the late endosome and endolysosome but not type I IFN KM Pollard, GM Escalante, H Huang, KM Haraldsson, P Hultman, ... The Journal of Immunology 199 (11), 3739-3747, 2017 | 23 | 2017 |
Four Decades of Prophylactic EBV Vaccine Research: A Systematic Review and Historical Perspective GM Escalante, LZ Mutsvunguma, M Muniraju, E Rodriguez, JG Ogembo Frontiers in immunology 13, 2022 | 20 | 2022 |
Kaposi sarcoma-associated herpesvirus glycoprotein H is indispensable for infection of epithelial, endothelial, and fibroblast cell types M Muniraju, LZ Mutsvunguma, J Foley, GM Escalante, E Rodriguez, ... Journal of Virology 93 (16), e00630-19, 2019 | 16 | 2019 |